Results 131 to 140 of about 197,670 (242)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Impact of immigration on outcomes following acute decompensated heart failure: A retrospective cohort study

ESC Heart Failure, EarlyView.
Abstract Aims The study aims to investigate the impact of immigration status on short‐ and long‐term outcomes in patients hospitalized with acute decompensated heart failure (ADHF). Methods We conducted a retrospective cohort study at a single centre, analysing 7457 patients admitted for ADHF between 2007 and 2017, with follow‐up until 2020 (mean 3.7 ± 
Gil Marcus, Antoinette Monayer, Amitai Low, Shiri L. Maymon, Ady Orbach, Eran Kalmanovich, Gil Moravsky, Avishay Grupper, Shmuel Fuchs, Sa'ar Minha   +9 more
wiley   +1 more source

Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantation

ESC Heart Failure, EarlyView.
Abbreviations: TAVI, transcatheter aortic valve implantation; ATTR‐CM, transthyretin cardiac amyloidosis. We aimed to diagnose occult ATTR‐CM in patients with severe aortic stenosis undergoing TAVI using bone scintigraphy. We verified a diagnosis of ATTR‐CM in 8 of 171 (4.7 %) consecutive aortic stenosis patients who underwent TAVI.
Margrethe Flesvig Holt, August Flø, Esra Kaya, Sophie Foss Kløve, Hege Martinsen, Kristine Amlie, Petter Storsten, Thomas Misje Mathiisen, Kristoffer Russell, Christian Hesbø Eek, Helge Skulstad, Melinda Raki, Lars Gullestad, Anders Hodt, Einar Gude, Kaspar Broch   +15 more
wiley   +1 more source

Diagnostic, pharmacological, and ablation approaches for idiopathic ventricular fibrillation: the 2024 European Heart Rhythm Association survey. [PDF]

Europace
Conte G, Metzner A, Anic A, Perrotta L, Penela D, Chun J.   +5 more
europepmc   +1 more source

Microaxial pump‐supported coronary surgery without CPB to optimize outcome in severely impaired left ventricles

ESC Heart Failure, EarlyView.
Abstract Aims Cardiopulmonary bypass (CPB) is the standard approach for coronary artery bypass grafting (CABG) in advanced ischaemic cardiomyopathy. Microaxial pump support has been envisioned to allow for beating‐heart CABG without CPB (MPCAB), thereby avoiding CPB‐inherent complications.
Anna Kathrin Assmann, Merve Arik‐Doganay, Sebastian Waßenberg, Payam Akhyari, Artur Lichtenberg, Alexander Assmann   +5 more
wiley   +1 more source

Prevalence of ventricular parasystole in patients with cardiac sarcoidosis: correlation between parasystole and inflammation in ventricular fibrillation. [PDF]

Open Heart
Ikee T, Nakajima K, Ishibashi K, Tateishi E, Tonegawa-Kuji R, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Ueda N, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Fukuda T, Kusano K.   +17 more
europepmc   +1 more source

Survival after myocardial infarction according to left ventricular function and heart failure symptoms

ESC Heart Failure, EarlyView.
Asymptomatic reduced left ventricular ejection fraction (LVEF) in the acute phase of myocardial infarction (AMI) was associated with up to 20% 1‐year mortality after discharge, substantially higher than in recent post‐MI trials. Symptoms of heart failure (HF) during the index hospitalization was associated with worse outcomes in patients with preserved
Jarle Jortveit, Peder L. Myhre, Kristian Berge, Sigrun Halvorsen   +3 more
wiley   +1 more source

A multicentre registry of hospitalized patients with acute and chronic heart failure: Study design of the H2‐registry

ESC Heart Failure, EarlyView.
The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner, Sebastian König, Anne Nitsche, Sven Hohenstein, Jana Nagel, Melchior Seyfarth, Henning Baberg, Alexander Lauten, Hans Neuser, Alexander Staudt, Jürgen Tebbenjohanns, René Andrié, Michael Niehaus, Markus W. Ferrari, Ralf Kuhlen, Andreas Bollmann   +15 more
wiley   +1 more source

Persistence of atrial mechanical systole and arterial pulse during ventricular fibrillation: The atrial pulse. [PDF]

Resusc Plus
Pappalardo F, D'Ettore N, Ambrosi S, Montisci A.   +3 more
europepmc   +1 more source

DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock

ESC Heart Failure, EarlyView.
Flow chart illustrates the analysed patients as well as main baseline characteristics and outcomes comparing DanGer Shock‐like versus DanGer Shock‐unlike patients. The composite safety endpoint comprises severe bleeding, limb ischaemia, haemolysis, device failure, and worsening of aortic regurgitation. CS indicates cardiogenic shock.
Norman Mangner, Johannes Mierke, Dominik Baron, Felix J. Woitek, Stephan Haussig, Thomas Nowack, Ephraim B. Winzer, Julia Fischer, Robert Höllriegel, Stefanie Jellinghaus, Axel Linke   +10 more
wiley   +1 more source